Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: role of cyclooxygenase

J Surg Res. 2000 May 15;90(2):138-43. doi: 10.1006/jsre.2000.5869.

Abstract

Background: Pulmonary vascular resistance is frequently elevated after cardiopulmonary bypass (CPB). We examined if altered pulmonary microvascular reactivity to serotonin (5-HT) is due to altered expression of isoforms of nitric oxide synthase (NOS) or cyclooxygenase (COX).

Materials and methods: Pigs (n = 8) were heparinized and placed on total CPB for 90 min and then perfused off CPB for 90 min. Noninstrumented pigs (n = 6) served as controls for vascular studies. Relaxation responses (% of precontraction) of microvessels (60-150 microm in diameter) were examined in vitro in a pressurized (20 mm Hg) no-flow state with video microscopic imaging. Expression of eNOS, iNOS, and inducible (COX-2) and constitutive (COX-1) cyclooxygenase was examined with Western blotting and reverse transcription polymerase chain reaction.

Results: Pulmonary vascular resistance (PVR) increased from 316 +/- 39 mm Hg x s/cm(5) at baseline to 495 +/- 53 at 60 min and 565 +/- 62 at 90 min after termination of CPB. 5-HT elicited a relaxation response (46.8 +/- 11. 8%) in precontracted control microvessels. This response was not affected by the NOS inhibitor N(G)-nitro-l-arginine. After CPB, pulmonary microvessels contracted significantly to 5-HT (-29 +/- 27%, P < 0.05 vs control). This response was partially inhibited (7 +/- 20%, P = 0.06) in the presence of the COX-2 inhibitor NS398, but was unaffected by the thromboxane synthase inhibitor U63557A (-20 +/- 19%). Expression of iNOS or COX-1 was not changed after CPB. Protein and mRNA expressions of COX-2 both increased significantly after CPB, while that of eNOS decreased by approximately 50%.

Conclusions: PVR increased after CPB. This was associated with a hypercontractile response of isolated pulmonary microvessels to 5-HT that was in part mediated by the release of prostaglandins (but not thromboxane) and associated with increased expression of COX-2 and with decreased expression of eNOS.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cardiopulmonary Bypass*
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Female
  • Free Radical Scavengers / pharmacology*
  • Gene Expression Regulation, Enzymologic
  • In Vitro Techniques
  • Isoenzymes / analysis
  • Isoenzymes / genetics
  • Isoenzymes / metabolism*
  • Lung / blood supply
  • Lung / enzymology
  • Male
  • Microcirculation / physiology
  • Nitric Oxide Synthase / analysis
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Nitroprusside / pharmacology
  • Postoperative Complications / drug therapy
  • Postoperative Complications / metabolism
  • Prostaglandin-Endoperoxide Synthases / analysis
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Pulmonary Circulation / drug effects*
  • Pulmonary Wedge Pressure / drug effects
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / metabolism
  • Serotonin / pharmacology*
  • Swine
  • Vascular Resistance / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Free Radical Scavengers
  • Isoenzymes
  • Vasodilator Agents
  • Nitroprusside
  • Serotonin
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases